| Andrew Christopher D'orazio, RPH | |
|
10 Benning St, West Lebanon, NH 03784-3402 | |
| (603) 298-7828 | |
| Not Available |
| Full Name | Andrew Christopher D'orazio |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 10 Benning St, West Lebanon, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649946765 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PHCY-01185 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Christopher D'orazio, RPH 42 Wolf Rd, Lebanon, NH 03766-1950 Ph: (207) 423-4092 | Andrew Christopher D'orazio, RPH 10 Benning St, West Lebanon, NH 03784-3402 Ph: (603) 298-7828 |
News Archive
Cognitive testing by telephone in elderly individuals is generally as effective as in-person testing, according to a new study by Effie M. Mitsis, PhD, Assistant Professor of Psychiatry at Mount Sinai School of Medicine and part of Mount Sinai's Alzheimer's Disease Research Center. The study will appear in the International Journal of Geriatric Psychiatry.
Future trends in global population growth could be significantly affected by improvements in both the quality and quantity of education, particularly female education. Projections of future population trends that do not explicitly include education in their analysis may be flawed, according to research published today in the journal Science (July 29 2011).
Researchers might be able to treat a troublesome cough in disease without disrupting the protective cough we need for optimal lung health, by targeting the different brain circuits involved. That's according to new research published this week in The Journal of Physiology.
In a new study published in Disease Models & Mechanisms, scientists use the zebrafish to gain insight into the influence of known cancer genes on the development and progression of melanoma, an aggressive form of human skin cancer with limited treatment options.
Anadys Pharmaceuticals, Inc. announced today that it has initiated the planned Phase IIb study of ANA598 in combination with pegylated interferon and ribavirin. The protocol for the study has been cleared by the United States Food and Drug Administration and Health Canada.
› Verified 7 days ago
Erich Mussgnug, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Plainfield Rd, West Lebanon, NH 03784 Phone: 603-298-8350 Fax: 603-298-0547 | |
Robert Maynard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Airport Rd, West Lebanon, NH 03784 Phone: 603-298-5796 | |
Urvi Teli, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Benning St, West Lebanon, NH 03784 Phone: 603-298-7828 Fax: 603-298-7017 | |
Donald Rastani, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Airport Rd, West Lebanon, NH 03784 Phone: 603-298-5796 | |
Dr. Dorota Strzelecki, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Airport Rd, West Lebanon, NH 03784 Phone: 603-298-5391 | |
Michael W Stallbohm, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Airport Rd, West Lebanon, NH 03784 Phone: 603-298-5796 | |
Dr. Anna Louise Cody, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Airport Rd, West Lebanon, NH 03784 Phone: 603-298-5796 |